Mirvetuximab Soravtansine and Carboplatin for Treatment of Patients With Recurrent Folate Receptor Alpha–Positive Platinum-Sensitive Ovarian Cancer: A Final Analysis
IMMUNOGEN IS NOW PART OF ABBVIE
Together we will be working to make a remarkable impact for cancer patients and their communities of care, raising standards of care and advancing a dynamic oncology pipeline.